State Street’s BioXcel Therapeutics BTAI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $135K | Buy |
|
|||||
|
2025
Q1 | – | Sell |
|
|||||
|
2024
Q4 | $28.8K | Hold |
|
|||||
|
2024
Q3 | $47.1K | Sell |
|
|||||
|
2024
Q2 | $160K | Sell |
|
|||||
|
2024
Q1 | $1.31M | Buy |
|
|||||
|
2023
Q4 | $1.3M | Buy |
|
|||||
|
2023
Q3 | $1.04M | Sell |
|
|||||
|
2023
Q2 | $13.8M | Buy |
|
|||||
|
2023
Q1 | $32.9M | Buy |
|
|||||
|
2022
Q4 | $7.92M | Sell |
|
|||||
|
2022
Q3 | $4.37M | Buy |
|
|||||
|
2022
Q2 | $4.82M | Sell |
|
|||||
|
2022
Q1 | $29.3M | Buy |
|
|||||
|
2021
Q4 | $27.3M | Buy |
|
|||||
|
2021
Q3 | $40.3M | Sell |
|
|||||
|
2021
Q2 | $42.4M | Buy |
|
|||||
|
2021
Q1 | $55.1M | Sell |
|
|||||
|
2020
Q4 | $77.3M | Buy |
|
|||||
|
2020
Q3 | $56.1M | Buy |
|
|||||
|
2020
Q2 | $51.7M | Buy |
|
|||||
|
2020
Q1 | $2.82M | Buy |
|
|||||
|
2019
Q4 | $1.46M | Buy |
|
|||||
|
2019
Q3 | $597K | Buy |
|
|||||
|
2019
Q2 | $526K | Buy |
|